Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer

NCT02292173 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Cancer
Liver Cancer

Interventions

DRUG: Trametinib
DRUG: Sorafenib

Sponsor

H. Lee Moffitt Cancer Center and Research Institute